Please provide your email address to receive an email when new articles are posted on . The FDA has pledged to reduce animal testing for monoclonal antibodies. The decision reflects longstanding ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, ...

A review by University of Manchester scientists says sophisticated lab-grown tumors could help fast-track the search for new ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA's new draft guidance clarifies how companies can gain regulatory validation for their alternative preclinical model.

The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...

During a joint workshop on Monday, officials from the US Food and Drug Administration (FDA) and National Institutes of Health (NIH) outlined efforts to reduce animal testing. FDA Commissioner Marty ...

Ian explains how AI is helping the FDA finally rethink how we decide when a new drug is safe enough to test on people.

RFK Jr.’s moves to limit animal testing in drug trials could pull animal rights voters into the Republican camp, experts say.

The U.S. Food and Drug Administration on Friday proposed to reduce animal studies conducted to assess safety in the development of certain cancer medications, marking the agency’s latest effort to ...

Following the U.S. Food and Drug Administration's (FDA) April 2025 roadmap to reduce reliance on animal testing in preclinical safety studies, which stated that it would develop pathways for both ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...